Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.

导出 OA

翻译打印收藏纠错

作者： Larry M,Baddour ^[1] ; Raul,Weiss ^[2] ; George E,Mark ^[3] ; Mikhael F,El-Chami ^[4] ; Mauro,Biffi ^[5] ; Vincent,Probst ^[6] ; Pier D,Lambiase ^[7] ; Marc A,Miller ^[8] ; Timothy,McClernon ^[9] ; Linda K,Hansen ^[10] ; Bradley P,Knight ^[11]

作者单位： Division of Infectious Diseases, Department of Medicine, and Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota. ^[1] The Ohio State University Wexner Medical Center, Cardiology, DHLRI, Columbus, Ohio. ^[2] Department of Cardiology, Cooper University Hospital, Camden, New Jersey. ^[3] Division of Cardiology, Section of Electrophysiology, Emory University Hospital, Atlanta, Georgia. ^[4] Institute of Cardiology, S. Orsola Malpighi Hospital, Bologna, Italy. ^[5] L'Institut du Thorax, CHU de Nantes, Cardiology, Nantes, France. ^[6] UCL Institute of Cardiovascular Science, and Barts Heart Center, London, UK. ^[7] Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York. ^[8] People Architects, Inc., Minneapolis. ^[9] Boston Scientific Corp., St. Paul, Minnesota. ^[10] Center for Heart Rhythm Disorders Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, Illinois. ^[11]

关键词 antibiotics diagnosis extraction infection mapping subcutaneous implantable cardioverter-defibrillator

主题词除颤器, 植入型(Defibrillators, Implantable);设备污染(Equipment Contamination);人类(Humans);假体相关感染(Prosthesis-Related Infections)

DOI 10.1111/pace.13902

PMID 32267974

发布时间 2021-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交